Renal Cancer - Results from #3960

Immune associated LncRNAs identify novel prognostic subtypes of renal clear cell carcinoma. December 11, 2018

Prognostic significance of body mass index in patients with localized renal cell carcinoma. December 10, 2018

Construction of immune-related risk signature for renal papillary cell carcinoma. December 10, 2018

Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity. December 10, 2018

Assessment of Overall Survival, Quality of Life, and Safety Benefits Associated With New Cancer Medicines December 9, 2018

A Global Comparison of the Cost of Patented Cancer Drugs in Relation to Global Differences in Wealth December 9, 2018

Biomarker-Based Phase II Trial of Savolitinib in Patients with Advanced Papillary Renal Cell Cancer December 9, 2018

Unclassified renal cell carcinoma: diagnostic difficulties and treatment modalities. December 7, 2018

Leukocyte‑associated immunoglobulin‑like receptor 1 promotes tumorigenesis in RCC. December 7, 2018

Pazopanib: Evidence review and clinical practice in the management of advanced renal cell carcinoma. December 7, 2018

Bone metastases and age are associated with earlier dose reductions in metastatic clear-cell renal cell carcinoma patients treated with angiogenesis inhibitors. December 6, 2018

Chronic kidney cortical damage is associated with baseline kidney function and albuminuria in patients managed with radical nephrectomy for kidney tumours. December 6, 2018

CircRNA ZNF609 functions as a competitive endogenous RNA to regulate FOXP4 expression by sponging miR-138-5p in renal carcinoma. December 6, 2018

[French ccAFU guidelines - Update 2018-2020: Management of kidney cancer]. December 6, 2018

Application of Chromosome Microarray Analysis for the Differential Diagnosis of Low-grade Renal Cell Carcinoma With Clear Cell and Papillary Features. December 5, 2018

Structure base Virtual screening for the identification of high affinity compounds as potent VEGFR2 inhibitors for the treatment of Renal Cell Carcinoma. December 5, 2018

Metastatic clear cell renal carcinoma to the auricular region disguised as a vascular thrombus: Case report. December 5, 2018

Pre- and post-operative anti-PD-L1 plus anti-angiogenic therapies in mouse breast or renal cancer models of micro- or macro-metastatic disease. December 5, 2018

Efficacy, safety, and prognostic indicators of first-line sunitinib in patients with metastatic renal cell carcinoma: A single center experience. December 4, 2018

Metabolic control of PPAR activity by aldehyde dehydrogenase regulates invasive cell behavior and predicts survival in hepatocellular and renal clear cell carcinoma. December 4, 2018

Page 199 of 456